HB-201 IV

TERMINATED · EARLY_PHASE1 · HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer

Sponsor decision.

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.